{
    "Symbol": "JNJ",
    "AssetType": "Common Stock",
    "Name": "Johnson & Johnson",
    "Description": "Johnson & Johnson (J&J) is an American multinational corporation founded in 1886 that develops medical devices, pharmaceuticals, and consumer packaged goods. Its common stock is a component of the Dow Jones Industrial Average and the company is ranked No. 36 on the 2021 Fortune 500 list of the largest United States corporations by total revenue. Johnson & Johnson is one of the world's most valuable companies, and is one of only two U.S.-based companies that has a prime credit rating of AAA, higher than that of the United States government.",
    "CIK": "200406",
    "Exchange": "NYSE",
    "Currency": "USD",
    "Country": "USA",
    "Sector": "LIFE SCIENCES",
    "Industry": "PHARMACEUTICAL PREPARATIONS",
    "Address": "ONE JOHNSON & JOHNSON PLZ, NEW BRUNSWICK, NJ, US",
    "FiscalYearEnd": "December",
    "LatestQuarter": "2022-12-31",
    "MarketCapitalization": "475401224000",
    "EBITDA": "32717001000",
    "PERatio": "22.68",
    "PEGRatio": "3.793",
    "BookValue": "29.39",
    "DividendPerShare": "4.45",
    "DividendYield": "0.0293",
    "EPS": "6.72",
    "RevenuePerShareTTM": "36.17",
    "ProfitMargin": "0.189",
    "OperatingMarginTTM": "0.271",
    "ReturnOnAssetsTTM": "0.0871",
    "ReturnOnEquityTTM": "0.238",
    "RevenueTTM": "94943003000",
    "GrossProfitTTM": "63954000000",
    "DilutedEPSTTM": "6.72",
    "QuarterlyEarningsGrowthYOY": "-0.254",
    "QuarterlyRevenueGrowthYOY": "-0.044",
    "AnalystTargetPrice": "181.75",
    "TrailingPE": "22.68",
    "ForwardPE": "16.89",
    "PriceToSalesRatioTTM": "4.894",
    "PriceToBookRatio": "6.16",
    "EVToRevenue": "4.763",
    "EVToEBITDA": "15.47",
    "Beta": "0.534",
    "52WeekHigh": "181.77",
    "52WeekLow": "150.71",
    "50DayMovingAverage": "162.47",
    "200DayMovingAverage": "169.36",
    "SharesOutstanding": "2604290000",
    "DividendDate": "2023-03-07",
    "ExDividendDate": "2023-02-17"
}